These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 39252018

  • 1. ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder-the influence of impulsivity as a mediating factor.
    Beslot A, Grall-Bronnec M, Balem M, Schreck B, Laforgue EJ, Victorri-Vigneau C, Guillou-Landreat M, Leboucher J, OPAL-Group, Challet-Bouju G, Cabelguen C.
    Harm Reduct J; 2024 Sep 09; 21(1):165. PubMed ID: 39252018
    [Abstract] [Full Text] [Related]

  • 2. Attention-deficit/hyperactivity disorder combined subtype exacerbates opioid use disorder consequences: Mediation by impulsive phenotypes.
    Browning L, Cannoy CN, Moses TEH, Lundahl LH, Ledgerwood DM, Greenwald MK.
    Drug Alcohol Depend; 2024 Jun 01; 259():111292. PubMed ID: 38640865
    [Abstract] [Full Text] [Related]

  • 3. Comparison of opioid use disorder patients with and without problematic internet use in terms of impulsivity and attention deficit hyperactivity disorder.
    Bal NB, Örnek BY.
    Braz J Psychiatry; 2024 Jun 01; 46():e20243585. PubMed ID: 38636082
    [Abstract] [Full Text] [Related]

  • 4. Gaps in Evidence-based Treatment of Concurrent Attention Deficit Hyperactivity Disorder and Opioid Use Disorder: A Scoping Review.
    Ramey OL, Bonny AE, Silva Almodóvar A, Nahata MC.
    Ann Pharmacother; 2023 Aug 01; 57(8):978-990. PubMed ID: 36510631
    [Abstract] [Full Text] [Related]

  • 5. ADHD Prevalence among Outpatients with Severe Opioid Use Disorder on Daily Intravenous Diamorphine and/or Oral Opioid Maintenance Treatment.
    Rohner H, Gaspar N, Rosen H, Ebert T, Kilarski LL, Schrader F, Al Istwani M, Lenz AJ, Dilg C, Welskop A, Goldmann T, Schmidt U, Philipsen A.
    Int J Environ Res Public Health; 2023 Jan 31; 20(3):. PubMed ID: 36767906
    [Abstract] [Full Text] [Related]

  • 6. 2D:4D ratio, alexithymia, impulsivity, aggression, and ADHD in men with opioid and methamphetamine use disorders: A comparative analysis with healthy controls.
    Akkuş M, Avşar PA.
    Early Hum Dev; 2024 Feb 31; 189():105946. PubMed ID: 38280313
    [Abstract] [Full Text] [Related]

  • 7. The indirect effects of childhood attention deficit hyperactivity disorder on alcohol problems in adulthood through unique facets of impulsivity.
    Pedersen SL, Walther CA, Harty SC, Gnagy EM, Pelham WE, Molina BS.
    Addiction; 2016 Sep 31; 111(9):1582-9. PubMed ID: 26999438
    [Abstract] [Full Text] [Related]

  • 8. Impulsive Personality Traits Mediate the Relationship Between Attention-Deficit/Hyperactivity Disorder Symptoms and Psychiatric Comorbidity among Patients with Severe Alcohol Use Disorder.
    Brandt L, Levin FR, Kraigher D.
    J Dual Diagn; 2021 Sep 31; 17(3):193-206. PubMed ID: 34313557
    [Abstract] [Full Text] [Related]

  • 9. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
    Mauro PM, Gutkind S, Annunziato EM, Samples H.
    JAMA Netw Open; 2022 Mar 01; 5(3):e223821. PubMed ID: 35319762
    [Abstract] [Full Text] [Related]

  • 10. Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway.
    Karlstad Ø, Furu K, Skurtveit S, Selmer R.
    Eur Addict Res; 2014 Mar 01; 20(2):59-65. PubMed ID: 24080771
    [Abstract] [Full Text] [Related]

  • 11. The cascade of care for commercially-insured persons with opioid use disorder and comorbid HIV and HCV infections.
    Ivasiy R, Madden LM, DiDomizio E, Johnson KA, Machavariani E, Ahmad B, Oliveros D, Ram A, Kil N, Altice FL.
    Drug Alcohol Depend; 2024 Oct 01; 263():112410. PubMed ID: 39159600
    [Abstract] [Full Text] [Related]

  • 12. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails.
    Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA.
    JAMA Netw Open; 2024 Sep 03; 7(9):e2434704. PubMed ID: 39316401
    [Abstract] [Full Text] [Related]

  • 13. The cascade of care for opioid use disorder among youth in British Columbia, 2018.
    Krebs E, Min JE, Zhou H, Davison C, McGowan G, Nosyk B.
    J Subst Abuse Treat; 2021 Nov 03; 130():108404. PubMed ID: 34118696
    [Abstract] [Full Text] [Related]

  • 14. Impulsivity and its association with childhood trauma experiences across bipolar disorder, attention deficit hyperactivity disorder and borderline personality disorder.
    Richard-Lepouriel H, Kung AL, Hasler R, Bellivier F, Prada P, Gard S, Ardu S, Kahn JP, Dayer A, Henry C, Aubry JM, Leboyer M, Perroud N, Etain B.
    J Affect Disord; 2019 Feb 01; 244():33-41. PubMed ID: 30336349
    [Abstract] [Full Text] [Related]

  • 15. The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder.
    Dever JA, Hertz MF, Dunlap LJ, Richardson JS, Wolicki SB, Biggers BB, Edlund MJ, Bohm MK, Turcios D, Jiang X, Zhou H, Evans ME, Guy GP.
    Public Health Rep; 2024 Feb 01; 139(4):484-493. PubMed ID: 38268479
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, PROUD Collaborative Investigators.
    Drug Alcohol Depend; 2020 Feb 01; 207():107732. PubMed ID: 31835068
    [Abstract] [Full Text] [Related]

  • 17. Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.
    Welsh JW, Dennis ML, Funk R, Mataczynski MJ, Godley MD.
    J Subst Abuse Treat; 2022 Jan 01; 132():108584. PubMed ID: 34391589
    [Abstract] [Full Text] [Related]

  • 18. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C, Kramer CT, Terplan M, Fiscella K, Olson S, Voegtline K, Latkin C.
    JAMA Netw Open; 2022 Jan 04; 5(1):e2144369. PubMed ID: 35050354
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.
    Lee S, Sun L, Vakkalanka JP.
    Am J Emerg Med; 2024 Aug 04; 82():52-56. PubMed ID: 38795424
    [Abstract] [Full Text] [Related]

  • 20. Gambling and Attention Deficit Hyperactivity Disorders (ADHD) in a Population of French Students.
    Romo L, Rémond JJ, Coeffec A, Kotbagi G, Plantey S, Boz F, Kern L.
    J Gambl Stud; 2015 Dec 04; 31(4):1261-72. PubMed ID: 25466366
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.